Capital Investment Advisory Services LLC Purchases New Holdings in Astera Labs, Inc. $ALAB

Capital Investment Advisory Services LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to its most recent filing with the SEC. The firm acquired 6,574 shares of the company’s stock, valued at approximately $1,287,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares during the last quarter. 1832 Asset Management L.P. raised its stake in shares of Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after buying an additional 929,600 shares during the last quarter. Holocene Advisors LP acquired a new position in Astera Labs in the second quarter valued at approximately $55,827,000. State Street Corp boosted its stake in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after acquiring an additional 604,363 shares during the last quarter. Finally, Pacer Advisors Inc. acquired a new stake in Astera Labs during the 3rd quarter worth $100,475,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Needham & Company LLC raised their price target on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Raymond James Financial assumed coverage on Astera Labs in a report on Friday, November 21st. They set a “hold” rating on the stock. TD Cowen restated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Finally, Roth Mkm increased their price target on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $190.63.

Insider Activity

In other news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director directly owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This trade represents a 8.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 4,620 shares of the business’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares in the company, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 576,936 shares of company stock worth $87,409,540. 12.50% of the stock is currently owned by insiders.

Astera Labs Price Performance

NASDAQ:ALAB opened at $169.85 on Friday. The business’s 50-day simple moving average is $164.18 and its 200-day simple moving average is $172.97. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a market capitalization of $28.69 billion, a PE ratio of 153.02, a price-to-earnings-growth ratio of 1.95 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. During the same period in the previous year, the firm posted $0.23 EPS. The firm’s revenue was up 103.9% compared to the same quarter last year. On average, research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.